{"disease":{"id":"thoracic-neoplasms","name":"thoracic neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06335290","title":"Radiotherapy Treatments for the Treatment of Thoracic District Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":13200,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT04235556","title":"Integrated Care Pathway in Oncology (PASSION)","phase":"","overall_status":"UNKNOWN","enrollment_count":1800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06494241","title":"Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06376084","title":"Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":532,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03134872","title":"A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":419,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT00880971","title":"Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":394,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04697446","title":"External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC","phase":"","overall_status":"UNKNOWN","enrollment_count":279,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT04222972","title":"A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":223,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07159659","title":"Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06104774","title":"The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"China Medical University Hospital","has_results":false},{"nct_id":"NCT04862780","title":"(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":177,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT06731517","title":"Comparison of Ultrasound, CT, and Classical Methods for Selecting Sizes and Placement of Left-Sided Double-Lumen Tubes","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT03389256","title":"Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT04589247","title":"Improving Cancer On-treatment Symptom Management","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT05988736","title":"Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT05993273","title":"Pain Control After VATS Anatomical Pulmonary Resections","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"University Hospital Padova","has_results":false},{"nct_id":"NCT07479199","title":"Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05521789","title":"Erector Spinae Block for Thoracic Surgery","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"George Washington University","has_results":false},{"nct_id":"NCT06917573","title":"PALACE: Cemiplimab Trial According to ctDNA Levels","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Fundación GECP","has_results":false},{"nct_id":"NCT06177925","title":"A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04751552","title":"Erector Spinae Block for Thoracoscopic Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT04741958","title":"Role of Ultrasound Guided Peripheral Thoracic Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT06546839","title":"SPSIPB vs SAPB for Thoracoscopic Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Medipol University","has_results":false},{"nct_id":"NCT03093909","title":"Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04776447","title":"Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Fundación GECP","has_results":false},{"nct_id":"NCT07242547","title":"Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Fundación GECP","has_results":false},{"nct_id":"NCT02909452","title":"Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT02897778","title":"Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT04725448","title":"Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT04556344","title":"Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03306693","title":"Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers","phase":"NA","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT05770869","title":"mHealth ALIBIRD: A Digital Health Care Model","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares","has_results":false},{"nct_id":"NCT05153408","title":"(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT04371796","title":"Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT03435952","title":"Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06758700","title":"Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT04227717","title":"Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04644315","title":"A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06841874","title":"Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false}],"total":40},"guidelines":[],"source":"Drug Landscape verified database"}